1. Home
  2. OBIO vs BLNK Comparison

OBIO vs BLNK Comparison

Compare OBIO & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • BLNK
  • Stock Information
  • Founded
  • OBIO 2017
  • BLNK 2009
  • Country
  • OBIO United States
  • BLNK United States
  • Employees
  • OBIO N/A
  • BLNK N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • BLNK Industrial Specialties
  • Sector
  • OBIO Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • OBIO Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • OBIO 291.7M
  • BLNK 295.1M
  • IPO Year
  • OBIO N/A
  • BLNK N/A
  • Fundamental
  • Price
  • OBIO $8.13
  • BLNK $3.48
  • Analyst Decision
  • OBIO Strong Buy
  • BLNK Strong Buy
  • Analyst Count
  • OBIO 2
  • BLNK 8
  • Target Price
  • OBIO $17.00
  • BLNK $7.44
  • AVG Volume (30 Days)
  • OBIO 246.8K
  • BLNK 5.2M
  • Earning Date
  • OBIO 08-08-2024
  • BLNK 08-06-2024
  • Dividend Yield
  • OBIO N/A
  • BLNK N/A
  • EPS Growth
  • OBIO N/A
  • BLNK N/A
  • EPS
  • OBIO N/A
  • BLNK N/A
  • Revenue
  • OBIO $2,216,000.00
  • BLNK $156,498,000.00
  • Revenue This Year
  • OBIO $17.90
  • BLNK $23.22
  • Revenue Next Year
  • OBIO $10.51
  • BLNK $28.76
  • P/E Ratio
  • OBIO N/A
  • BLNK N/A
  • Revenue Growth
  • OBIO N/A
  • BLNK 114.36
  • 52 Week Low
  • OBIO $4.22
  • BLNK $2.18
  • 52 Week High
  • OBIO $11.69
  • BLNK $7.25
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 59.20
  • BLNK 67.31
  • Support Level
  • OBIO $7.48
  • BLNK $2.79
  • Resistance Level
  • OBIO $8.20
  • BLNK $3.01
  • Average True Range (ATR)
  • OBIO 0.61
  • BLNK 0.17
  • MACD
  • OBIO 0.01
  • BLNK 0.08
  • Stochastic Oscillator
  • OBIO 78.93
  • BLNK 96.77

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.

Share on Social Networks: